MAPT and Alzheimer disease: In our study of early AD patients with significant amyloid-β deposition demonstrated by positron emission tomography (PET), the relationships between the distribution of THK5351 PET accumulation (reflecting tau burden), inflammation, and the resting-state functional network disruption were examined (Yokoi et al., 2018).